Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls

Acta Psychiatrica Scandinavica

Volumn 114, Issue 1, 2006, Pages 27-35

  Nilsson, B M ^a,b   Forslund, A H ^a   Olsson, R M ^b   Hambraeus, L ^c   Wiesel, F A ^a  

^a Children's Hospital   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Basal metabolism; Body composition; Body water; Energy metabolism; Schizophrenia; Weight gain

Indexed keywords

WATER;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WATER; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; FEMALE; HOMEOSTASIS; HUMAN; IMPEDANCE; MALE; MEASUREMENT; PRIORITY JOURNAL; SCHIZOPHRENIA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; BODY COMPOSITION; BODY WATER; CALORIMETRY, INDIRECT; ELECTRIC IMPEDANCE; ENERGY METABOLISM; FEMALE; HUMANS; MALE; REFERENCE VALUES; REST; SCHIZOPHRENIA; SKINFOLD THICKNESS;

EID: 33745092183     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2005.00700.x     Document Type: Article

References (33)

1. Bowman KM Edison JP Burladge SP. Biochemical studies in ten cases of dementia praecox. Boston Med Surg J 1922 187: 358 362.
2. Hoskins RG Sleeper F. Basal metabolism in schizophrenia. Arch Neurol Psychiatry 1929 21: 887 900.
3. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004 27: 596 601.
4. Newcomer JW Haupt DW Fucetola R et al. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 2002 59: 337 345.
5. Ösby U Correia N Brandt L Ekbom A Sparén P. Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Schizophr Res 2000 45: 21 28.
6. Joukamaa M Heliövaara M Knekt P Aromaa A Raitsalo R Lehtinen V. Mental disorders and cause-specific mortality. Br J Psychiatry 2001 179: 498 502.
7. Braceland FJ Meduna LJ Vaichulis JA. Delayed action of insulin in schizophrenia. Am J Psychiatry 1945 102: 108 110.
8. Ravussin E Lillioja S Knowler WC et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988 318: 467 472.
9. Dubois EF. Basal metabolism in health and disease. Philadelphia, PA: Lea and Febiger, 1927.
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Press, 1994.
11. Kay SR Fiszbein A Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987 13: 261 276.
12. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 1988 37: 287 381.
13. Sjödin A Forslund A Westerterp K Andersson A Forslund J Hambraeus L. The influence of physical activity on BMR. Medicine and Science in Sports and Exercise 1996 28: 85 91.
14. De weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949 109: 1 9.
15. FAO/WHO/UNU. Energy and protein requirements. Report of a joint FAO/WHO/UNU expert consultation. Technical Report Series. No 724. Geneva: WHO, 1985.
16. Watson PE Watson ID Batt RD. Total body water volumes for adult males and females estima from simple anthropometric measurements. Am J Clin Nutr 1980 33: 27 39.
17. Van marken Lichtenbelt WD Snel YEM Brummer R-JM Koppeschaar HPF. Deuterium and bromide dilution and bioimpedance spectrometry independently show that growth hormone-deficient adults have an enlarged extracellular water compartment related to intracellular water. J Clin Endocrinol Metab 1997 82: 907 911.
18. Forslund AH Johansson AG Sjödin A Bryding G Ljunghall S Hambraeus L. Evaluation of modified multicompartment models to calculate body composition in healthy males. Am J Clin Nutr 1996 63: 856 862.
19. Müller MJ Bosy-westphal A Kutzner D Heller M. Metabolically active components of fat-free mass and resting energy expenditure in humans: recent lessons from imaging technologies. Obes Rev 2002 3: 113 122.
20. Flyckt L Borg J Borg K et al. Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia. Biol Psychiatry 2000 47: 991 999.
21. Gothlef D Falk B Singer P et al. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 2002 159: 1055 1057.
22. Taylor DM McAskill R. Atypical antipsychotics and weight gain - a systematic review. Acta Psychiatr Scand 2000 101: 416 432.
23. Mcintyre RS Mancini DA Basile BS. Mechanisms of antipsychotic-induced weight gain. J Clin Psychiatry 2001 62 ( suppl. 23 23 29.
24. Reynolds GP. Zhang ZJ Zhang XB. Association of antipsychotic drug-induced weight gain with a HT2C receptor gene polymorphism. Lancet 2002 359: 2086 2087.
25. Henderson DC Cagliero E Gray C et al. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five year naturalistic study. Am J Psychiatry 2000 157: 975 981.
26. Ryan MCM Collins P Thakore JH. Impaired fasting glucose tolerance in first-episode drug-naive patients with schizophrenia. Am J Psychiatry 2003 160: 284 289.
27. Mercier-Guidez E Loas G. Polydipsia and water intoxication in 353 psychiatric inpatients, an epidemiological and psychopathological study. Eur Psychiatry 2000 15: 306 311.
28. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003 28 ( suppl. 2 17 54.
29. Huber TJ Borsutzky M Schneider U Emrich HM. Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis. Acta Psychiatr Scand 2004 109: 269 274.
30. Kulkarni J Riedel A De castella AR et al. Estrogen - a potential treatment for schizophrenia. Schizophr Res 2001 48: 137 144.
31. Wiesel F-A. Glucose metabolism in psychiatric disorders: how can we facilitate comparisons among studies J Neural Transm 1992 37 ( suppl. 37 1 18.
32. Kegeles LS Humaran TJ Mann JJ. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biol Psychiatry 1998 44: 382 398.
33. Ben-shachar D. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem 2002 83: 1241 1251.